Nadine Choueiter, MD

Nadine F. Choueiter, MD, is an Associate Professor of Pediatric Cardiology and Radiology and will be assuming the positions as Director of the Congenital Cardiac MRI Program and Co-Director of the Kawasaki Disease Follow-up Program at the Icahn School of Medicine at Mount Sinai and Mount Sinai Children’s Heart Center.

A graduate of the American University of Beirut, Dr. Choueiter earned her Bachelor of Science in Biology with distinction in 1999 followed by her Doctor of Medicine in 2003. She completed her training in pediatrics at the Children’s Medical Center Dallas, the University of Texas Southwestern Medical Center in 2007, and her fellowship in pediatric cardiology at Seattle Children’s Hospital, University of Washington School of Medicine in 2010. Dr. Choueiter then pursued a senior clinical fellowship in noninvasive imaging at Children's Hospital Boston, Harvard Medical School, in 2011. Following that, Dr. Choueiter worked at the Children's Hospital at Montefiore for over 10 years and served as the director of non-invasive pediatric cardiac imaging, the director of the John Gutfruend Fetal Heart Program, and the co-director of the Kawasaki disease and MIS-C follow up program.

She is a multimodality imager with expertise in magnetic resonance (MR) imaging, echocardiography, and fetal echocardiography for the diagnosis of congenital heart disease. She is also an expert in the management of cardiac complications in children with Kawasaki disease and MIS-C. Dr. Choueiter is often invited to speak at national and international conferences on the use of cardiac MR in pediatric and acquired congenital heart disease, Kawasaki disease, and MIS-C.

Dr. Choueiter is board certified in pediatrics, pediatric cardiology, and adult congenital heart disease. She is a member of several professional societies and is a fellow of the American Society of Echo and of the Society of Cardiac MR (SCMR). She currently serves on several national and international committees including the steering committee of the pediatric and congenital cardiac MR section of SCMR, the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, and on the international Kawasaki disease Registry (IKDR) steering committee. She is a founding member of the Kawasaki disease in the Arab World (Kawarabi).

Research Focus:
The focus of Dr. Choueiter's research is in pediatric and congenital cardiac MR, cardiac complications in the Kawasaki disease (KD) registry, and more recently the newly described entity the multisystem inflammatory syndrome in children (MIS-C).  She is particularly well known for her collaborative work with the international KD registry to determine the medium-term outcomes of children with KD and those with MIS-C. She has co-authored many papers on this topic. She is also the first author on the initial drug trial evaluating the safety of Etanercept in children with KD. She was the site principal investigator for the subsequent FDA-funded multicenter randomized trial evaluating the efficacy of etanercept in the same patient population. She is currently focused on developing quality metrics for the interpretation of cardiac MR in congenital heart disease.